Those who received vs did not receive SSRIs before and after sleeve gastrectomy had limited total weight loss at 1 year.

Robert Kauffman, MD, discusses the updated ACOG clinical guidance outlining pharmacologic and nonpharmacologic interventions for menopausal symptoms.

(HealthDay News) — Structured support may attenuate weight gain after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online Oct. 7 in Obesity ...

Class I obesity at incident dementia linked to 27 percent lower risk for mortality compared with normal weight ...

After multivariable adjustment, skipping breakfast and variable meal frequencies were not linked to MASLD, cirrhosis ...

Researchers evaluated the impact of menopausal hormone therapy on cardiovascular disease risk among women in midlife experiencing vasomotor symptoms.

In insulin-naive adults with T2D, once-weekly icodec plus semaglutide vs insulin glargine U100 showed superior glycemic control and weight loss.

The FDA has approved Enspryng (satralizumab-mwge) for thyroid eye disease in adults, offering the first at-home subcutaneous IL-6 receptor antagonist for TED.

The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity, according to a study.

For adults taking potassium-raising medications, greater consumption of dietary potassium as part of a DASH diet is not associated with hyperkalemia.

Endocrinology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...